Paloma Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Paloma Partners’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-100,000	Closed	-$27K	–	2318
2016 Q3	$27K	Hold	100,000	–	–	﹤0.01%	1791
2016 Q2	$24K	Hold	100,000	–	–	﹤0.01%	2120
2016 Q1	$11K	Hold	100,000	–	–	﹤0.01%	1819
2015 Q4	$11K	Hold	100,000	–	–	﹤0.01%	1666
2015 Q3	$19K	Hold	100,000	–	–	﹤0.01%	1568
2015 Q2	$70K	Hold	100,000	–	–	﹤0.01%	1710
2015 Q1	$68K	Hold	100,000	–	–	﹤0.01%	1141
2014 Q4	$79K	Hold	100,000	–	–	﹤0.01%	1081
2014 Q3	$47K	Hold	100,000	–	–	﹤0.01%	955
2014 Q2	$50K	Hold	100,000	–	–	﹤0.01%	1061
2014 Q1	$32K	Hold	100,000	–	–	﹤0.01%	650
2013 Q4	$34K	Sell	100,000 -375,000	-79%	-$453K	﹤0.01%	967
2013 Q3	$960K	Buy	475,000 +60,000	+14%	+$114K	0.04%	355
2013 Q2	$801K	Buy	+415,000	New	+$729K	0.04%	315

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

MCM

Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BCM

Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Paloma Partners's GCVRZ Position: Q4 2016 in Review

Paloma Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2016, closing a stake of 100,000 shares — an estimated $27K sold.

Paloma Partners first reported a position in GCVRZ in Q2 2013 and held it in 14 quarters. The position peaked at $960K in Q3 2013. 120 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2016.

Paloma Partners reported no remaining Sanofi Contingent Value Rights position as of Q4 2016 after selling out during the quarter.
Paloma Partners sold 100,000 Sanofi Contingent Value Rights shares in Q4 2016, an estimated $27K.
Paloma Partners first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 14 quarters.
Paloma Partners's Sanofi Contingent Value Rights position peaked at $960K in Q3 2013.
120 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2016.

Based on Paloma Partners's 13F filing for Q4 2016, filed 14 Feb 2017.